All stock lists
Unlock the score
Retension Pharmaceuticals, Inc. (NASDAQ:RTSN)
US · Delayed Price · Currency is USD
Healthcare · Medical - Pharmaceuticals
14.24-1.01 (-6.62%)
Insider Score
/ 100
RTSN Insider Score
Retension Pharmaceuticals, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
RTSN Stock Insider Trading Activity
RTSN stock’s insider trading shows 2 purchases for an estimated $369.60K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days2 qualifying buys2 insiders$369.60K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Keller Eric L. CEO | Buy | 20,800 | $12.00 | $249.60K | 5.2% | 423,377 | Oct 13, 2026 | BFirst BuyCEO Buy | Form 4 |
| Keller Eric L. CEO | Converted | 9,662 | — | — | 2.3% | 433,039 | Oct 13, 2026 | — | Form 4 |
| Keller Eric L. CEO | Converted | 31,368 | — | — | 7.2% | 464,407 | Oct 13, 2026 | — | Form 4 |
| Sweetnam Paul Other | Converted | 4,026 | — | — | 1.0% | 406,603 | Oct 13, 2026 | — | Form 4 |
| Sweetnam Paul Other | Converted | 2,640 | — | — | New | 2,640 | Oct 13, 2026 | — | Form 4 |
| Olds Donald Director | Converted | 5,637 | — | — | New | 5,637 | Oct 13, 2026 | — | Form 4 |
| Bisson Sabine COO | Converted | 1,611 | — | — | New | 1,611 | Oct 13, 2026 | — | Form 4 |
| Bisson Sabine COO | Converted | 2,504 | — | — | 155% | 4,115 | Oct 13, 2026 | — | Form 4 |
| BERGER FRANKLIN M Director | Converted | 12,517 | — | — | New | 12,517 | Oct 13, 2026 | — | Form 4 |
| BERGER FRANKLIN M Director | Buy | 10,000 | $12.00 | $120.00K | New | 10,000 | Oct 13, 2026 | AFirst Buy | Form 4 |
| BERENDT MICHAEL J Director | Converted | 4,026 | — | — | New | 4,026 | Oct 13, 2026 | — | Form 4 |
| BERENDT MICHAEL J Director | Converted | 2,640 | — | — | 65.6% | 6,666 | Oct 13, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Converted (C) — Conversion of a derivative security into shares
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.